SEC Info - Aronson Jeffrey, et al. - ‘3’ for 11/17/10 re: K-V Pharmaceutical Co.

SEC Info℠

Home

Help

Please Sign In

Aronson Jeffrey, et al. – ‘3’ for 11/17/10 re: K-V Pharmaceutical Co.

On: Monday, 11/29/10, at 5:27pm ET · For: 11/17/10 · As: 10% Owner · Accession #: 1140361-10-47367 · File #: 1-09601

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/29/10  Aronson Jeffrey                   3          10% Owner   2:50K  KV Pharmaceutical Co./DE          Edgarfilings Ltd.
          Gallogly Mark T
          Centerbridge Special Credit Advisors, L.L.C.
          Centerbridge Credit Advisors, L.L.C.
          Centerbridge Partners Holdings, LLC
          Centerbridge Partners, L.P.
          U.S. Healthcare I, L.L.C.
          U.S. Healthcare II, L.L.C.

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 3           Initial Statement of Beneficial Ownership of        HTML     14K 
                Securities by an Insider -- doc1.xml/2.3                         
 2: EX-99.1     Miscellaneous Exhibits                              HTML     22K

Filing Submission 0001140361-10-047367 – SGML Text

Original SGML Text submitted by:	Broadridge Financial Solutions, Inc. (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Aronson Jeffrey, et al. – ‘3’ for 11/17/10 re: K-V Pharmaceutical Co.

On: Monday, 11/29/10, at 5:27pm ET · For: 11/17/10 · As: 10% Owner · Accession #: 1140361-10-47367 · File #: 1-09601

Previous ‘3’: ‘3’ on 5/12/08 for 4/30/08 · Next: ‘3’ on / for 1/27/11 · Latest: ‘3/A’ on 1/26/22 for 1/12/22

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34Filing Table of Contents

To view the SGML, please refresh this page.

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34
Filing Table of Contents

To view the SGML, please refresh
this page.